Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Patents
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Alkermes falls in 4 out of last 5 days January 31, 2018 16:00 EST
Briefing.com: Hourly In Play (R) - 20:00 ET
SEC Filings: Form 424B3: Form of prospectus reflecting facts events constituting substantive change from last form 01/04/18
NDA for Novel Major Depressive Disorder Treatment Submitted to FDA
Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive Disorder
SEC Filings: Form 6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act 01/30/18
Change in the Board of Directors
Swiss Official Gazette of Commerce notice: HR of Canton Zug: No. of SOGC 026 from 07.02.2018/Notice no 4041105/New entries
Auris Medical Announces Extraordinary General Meeting of Shareholders
LC-MS/MS method for the determination of the prodrug aripiprazole lauroxil and its three metabolites in plasma and its application to in vitro biotransformation and animal pharmacokinetic studies
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »
×